If Dyk & Reyna show up again, then some actionable pushback needs to take place. I don't know what recourse an appellant would have, but it would be obvious that a coincidence of that magnitude is next to impossible.
Marjac, At the end of this, if Hikma is found to be inducing infringement, how does Amarin benefit? I have no doubt that there is a larger strategy here. I'm not quite sure what it is. Thanks, Sleven,
Except for the fact Amarin took it upon itself to change long standing FDA regulation by suing them... and won. This grudge will never go away as long as Amarin continues to do business in the U.S.A.. There's a cabal trying to prove that but no one believes it except the bears.